English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vifor Pharma
Press release submission
| Dec 10, 2021
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Nicholas Gueguen
| Aug 13, 2017
Vifor Pharma begins new tests of Ferinject in patients with heart failure, iron deficiency
Robert Hadley
| Apr 28, 2017
Vifor Pharma offers grants aimed at combating iron deficiency
Gene Johnson
| Mar 1, 2017
Vifor buys rights to sell renal treatment in most of Asia
Carol Ostrow
| Feb 16, 2017
Swiss company holds iron deficiency to the fire
Keri Carbaugh
| Jan 6, 2017
Kidney Health Alliance expands to include CCX140
Amanda Rupp
| Jun 11, 2016
Vifor Pharma grants Pfizer commercialization rights
Amanda Rupp
| May 25, 2016
Vifor Pharma buys rights to rare renal disease treatment
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
